-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $30

Benzinga·10/28/2026 10:05:01
Diffusion vocale
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $29 to $30.